Skin Cancer News

Designation for Advanced Cutaneous Squamous Cell Carcinoma (October 1, 2018)

Breakthrough Designation for Advanced Cutaneous Squamous Cell Carcinoma The U.S. Food and Drug Administration (FDA) has approved cemiplimab (REGN2810) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (CSCC) and adults with... Continue Reading

May Is National Skin Cancer Detection and Prevention Month (May 18, 2018)

Sun Valley, ID —OMNI Health  (OMNI) announces the launch of skin cancer programs for national skin cancer detection and prevention month. As the month of May brings skin cancer into focus, it’s time to increase public understanding of the disease,... Continue Reading

Tafinlar® + Mekinist® Demonstrates Long Term Survival Benefit for BRAF Mutation-Positive Metastatic Melanoma (April 5, 2018)

CancerConnect News: Metastatic melanoma patients with the BRAF V600 mutation treated with the combination of Tafinlar® (dabrafenib) + Mekinist® (trametinib) can experience long term cancer free survival according to results presented at the 53rdAnnual... Continue Reading

PD-1 Antibody Cemiplimab Appears Promising for Treatment of Squamous Cell Carcinoma of the Skin (February 2, 2018)

Cemiplimab an investigational human antibody targeting PD-1 (programmed cell death protein 1), is yet another “checkpoint inhibitor” that was evaluated in 82 patients with advanced cutaneous squamous cell carcinoma (CSCC).  Early trial results suggest... Continue Reading

Start 2018 Right: Plan for Cancer Screening and Save Lives! (January 5, 2018)

Screening guidelines should initiate conversations with your healthcare team.  Charles H Weaver MD, Editor CancerConnect CancerConnect News: The goal of cancer screening is to find disease at early stages in people who are otherwise asymptomatic—before... Continue Reading

Skin Cancer Prevention Tips from the Skin Cancer Foundation (May 17, 2017)

The development of skin cancer is certainly a risk for any individual, but particularly for those of us who spend time in the outdoors. As summer approaches it’s important to keep in mind that by taking certain steps to protect yourself from the sun,... Continue Reading

Check It Out: May is Skin Cancer Awareness Month (May 1, 2017)

Skin cancer is the most commonly diagnosed cancer in the United States. Although the majority of skin cancers fall under basal cell and squamous cell carcinomas (number of cases estimated to be around 5 million), most deaths are a result of melanoma which... Continue Reading

FDA Approves Bavencio as First Treatment for Merkel Cell Cancer (March 31, 2017)

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior... Continue Reading

Epacadostat Plus Keytruda® Appears Effective in Melanoma (October 11, 2016)

The treatment combination consisting of epacadostat plus Keytruda® (pembrolizumab) appears effective in the treatment of advanced melanoma. Melanoma is a type of skin cancer that often starts in the form of a mole. If detected and treatable with surgery,... Continue Reading

Promising Activity of Pembrolizumab in Merkel Cell Carcinoma (June 14, 2016)

Treatment of 26 patients with advanced previously untreated Merkel cell carcinoma with Keytruda® (pembrolizumab) every three weeks resulted in an overall response rate of 56% suggesting this novel therapy could represent a new treatment option for these... Continue Reading

Latest Skin Cancer News By Stage


General Skin Cancer

Check It Out: May is Skin Cancer Awareness Month (May 1, 2017)

Skin cancer is the most commonly diagnosed cancer in the United States. Although the majority of skin cancers fall under basal cell and squamous cell carcinomas (number of cases estimated to be around 5 million), most deaths are a result of melanoma which... Continue Reading

Promising Activity of Pembrolizumab in Merkel Cell Carcinoma (June 14, 2016)

Treatment of 26 patients with advanced previously untreated Merkel cell carcinoma with Keytruda® (pembrolizumab) every three weeks resulted in an overall response rate of 56% suggesting this novel therapy could represent a new treatment option for these... Continue Reading

National "Check Yourself to Protect Yourself ALL YEAR" Campaign Highlights Need for Year-Round Skin Cancer Prevention (November 12, 2015)

Although one in five Americans will get skin cancer in their lifetimes, 65 percent of people of color don’t believe they are at risk and face lower survival rates as a result. To change these odds, the cancer organization Patients Rising will use... Continue Reading

Patients with Multiple Squamous Cell Carcinomas Should be Frequently Monitored (October 21, 2015)

Patients with multiple sites of cutaneous squamous cell carcinoma (a type of skin cancer) have a significantly increased risk of developing a recurrence or spread to their lymph nodes, warranting frequent follow-up visits to their dermatologist. These... Continue Reading

Food and Drug Administration approves Odomzo for treatment of basal cell carcinoma (August 13, 2015)

The U. S. Food and Drug Administration approved Odomzo® (sonidegib, formerly LDE225) for the treatment of patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates... Continue Reading

More General Skin Cancer

Skin Cancer Overview

Progress in the Treatment of Advanced Melanoma and Other Skin Cancers (November 14, 2014)

By one estimate, over the past three decades more people in the United States have had skin cancer than all other cancers combined.1 According to the American Cancer Society, 3.5 million cases of basal and squamous cell skin cancer are diagnosed each... Continue Reading

More Skin Cancer Overview